Search results for " myocardial infarction."

showing 10 items of 239 documents

Increased levels of C-reactive protein and fibrinogen influence the risk of vascular events in patients with NIDDM

2004

AIM: To evaluate the predictive role of hs-CRP and fibrinogen for cardio- and cerebrovascular events in a population of patients with type 2 diabetes. METHODS: We studied 156 patients with type 2 diabetes, mean age 66+10 years, and 156 sex and age matched control subjects. Patients underwent physical examination, EKG, measurement of body mass index and blood pressure. A blood sample was drawn to evaluate glycaemia, total and HDL/LDL cholesterol, triglycerides, high sensitive C-reactive protein (hs-CRP), fibrinogen. Finally, patients underwent an ecocolordoppler examination of the common carotid arteries until the bifurcation. In a follow-up of 5+/-1.2 years we evaluated the following events…

Malemedicine.medical_specialtyHeart diseasePopulationType 2 diabetesFibrinogenRisk FactorsInternal medicineDiabetes mellitusPrevalenceHumansMedicineMyocardial infarctioneducationAgededucation.field_of_studyChi-Square Distributionbiologybusiness.industryUnstable anginaC-reactive proteinFibrinogenAcute myocardial infarction C-reactive protein Diabetes mellitusmedicine.diseaseCerebrovascular DisordersC-Reactive ProteinEndocrinologyDiabetes Mellitus Type 2Cardiovascular DiseasesCase-Control Studiesbiology.proteinCardiologyFemaleCardiology and Cardiovascular Medicinebusinessmedicine.drugInternational Journal of Cardiology
researchProduct

Impact of routine invasive strategy on outcomes in patients with non-ST-segment elevation myocardial infarction during 2005–2014: A report from the P…

2020

Background: Non-ST-segment elevation myocardial infarction (NSTEMI) has become the most frequently encountered type of myocardial infarction. The patient clinical profile and management has evolved over the past decade. As there is still a scarcity of data on the latest trends in NSTEMI, changes herein were observed and assessed in the treatment and outcomes in Poland between 2005 and 2014. Methods: A total of 197,192 patients with NSTEMI who enrolled in the Polish Registry of Acute Coronary Syndromes (PL-ACS) between 2005 and 2014 were analyzed. In-hospital and 12-month mortality were assessed. Results: Coronary angiography use increased from 35.8% in 2005–2007 to 90.7% in 2012–2014 (p < 0…

Malemedicine.medical_specialtyInvasive strategyMultivariate analysismedicine.medical_treatmentnon-ST-elevation myocardial infarctionMyocardial InfarctionClinical CardiologyoutcomesCoronary AngiographyVentricular Function Lefttemporal trendsPercutaneous Coronary InterventionRisk FactorsInternal medicinemedicineST segmentHumansinvasive strategyMyocardial infarctionRegistriesAcute Coronary SyndromeChildNon-ST Elevated Myocardial Infarctionbusiness.industryMortality ratePercutaneous coronary interventionStroke VolumeGeneral MedicineOdds ratioMiddle Agedmedicine.diseaseConfidence intervalTreatment OutcomeCardiologyFemalePolandCardiology and Cardiovascular Medicinebusiness
researchProduct

Sum of ST-segment elevations on admission electrocardiograms in acute myocardial infarction predicts left ventricular dilation.

1996

In summary, ST-segment elevations on the admission electrocardiogram not only diagnose acute myocardial infarction but also provide predictive information with respect to developing infarct size and left ventricular remodeling as well as survival.

Malemedicine.medical_specialtyLeft ventricular dilationHeart VentriclesMyocardial InfarctionElectrocardiographyPatient AdmissionPredictive Value of TestsRisk FactorsInternal medicinemedicineST segmentHumanscardiovascular diseasesMyocardial infarctionVentricular remodelingAgedmedicine.diagnostic_testbusiness.industryST elevationMyocardiumElectrocardiography in myocardial infarctionMiddle Agedmedicine.diseasePredictive value of testscardiovascular systemCardiologyFemaleHypertrophy Left VentricularCardiology and Cardiovascular MedicinebusinessElectrocardiographyThe American journal of cardiology
researchProduct

Troponin I/ejection fraction ratio: A new index to differentiate Takotsubo cardiomyopathy from myocardial infarction

2015

– Transient hypokinesis, akinesis, or dyskinesis of the left ventricular mid-segments with or without apical involvement; the regional wall motion abnormalities extend beyond a single epicardial vascular distribution; a stressful trigger is often, but not always, present; – Absence of obstructive coronary disease or angiographic evidence of acute plaque rupture; – New ECG abnormalities (either ST-segment elevation and/or T wave inversion) or modest elevation in cardiac troponin; and – Absence of pheochromocytoma or myocarditis.

Malemedicine.medical_specialtyLeft ventricular ejection fractionMyocarditisCardiomyopathyMyocardial InfarctionAcute myocardial infarctionPheochromocytomaDiagnosis DifferentialElectrocardiographyTakotsubo CardiomyopathyT waveInternal medicineTroponin ImedicineHumansMyocardial infarctionAgedEjection fractionbiologybusiness.industryMedicine (all)Troponin IStroke VolumeMiddle Agedmedicine.diseaseTroponinSettore MED/11 - Malattie Dell'Apparato CardiovascolareTroponinbiology.proteinCardiologyFemalebusinessCardiology and Cardiovascular MedicineHuman
researchProduct

Risk score for early risk prediction by cardiac magnetic resonance after acute myocardial infarction.

2022

BACKGROUND: Cardiac magnetic resonance (CMR) performed early after ST-segment elevation myocardial infarction (STEMI) can improve major adverse cardiac event (MACE) risk prediction. We aimed to create a simple clinical-CMR risk score for early MACE risk stratification in STEMI patients.; METHODS: We performed a multicenter prospective registry of reperfused STEMI patients (n=1118) in whom early (1-week) CMR-derived left ventricular ejection fraction (LVEF), infarct size and microvascular obstruction (MVO) were quantified. MACE was defined as a combined clinical endpoint of cardiovascular (CV) death, non-fatal myocardial infarction (NF-MI) or re-admission for acute decompensated heart failur…

Malemedicine.medical_specialtyMagnetic Resonance SpectroscopyAcute decompensated heart failureMyocardial InfarctionMagnetic Resonance Imaging CineVentricular Function LeftPercutaneous Coronary InterventionRisk FactorsInternal medicineClinical endpointMedicineHumansMyocardial infarctioncardiovascular diseasesAgedFramingham Risk ScoreEjection fractionbusiness.industryMean ageStroke VolumeMiddle Agedmedicine.diseasePrognosiscardiovascular systemCardiologyST Elevation Myocardial InfarctionCardiology and Cardiovascular MedicinebusinessCardiac magnetic resonanceMace
researchProduct

EpCAM and microvascular obstruction in patients with STEMI: a cardiac magnetic resonance study

2020

Abstract Introduction and objectives Microvascular obstruction (MVO) is negatively associated with cardiac structure and worse prognosis after ST-segment elevation myocardial infarction (STEMI). Epithelial cell adhesion molecule (EpCAM), involved in epithelium adhesion, is an understudied area in the MVO setting. We aimed to determine whether EpCAM is associated with the appearance of cardiac magnetic resonance (CMR)-derived MVO and long-term systolic function in reperfused STEMI. Methods We prospectively included 106 patients with a first STEMI treated with percutaneous coronary intervention, quantifying serum levels of EpCAM 24 hours postreperfusion. All patients underwent CMR imaging 1 w…

Malemedicine.medical_specialtyMagnetic Resonance Spectroscopymedicine.medical_treatmentMagnetic Resonance Imaging Cine030204 cardiovascular system & hematologyVentricular Function Left03 medical and health scienceschemistry.chemical_compoundPercutaneous Coronary Intervention0302 clinical medicineInternal medicinemedicineHumansIn patientcardiovascular diseasesMyocardial infarctionVentricular remodelingEnd-systolic volumeAgedEjection fractionbusiness.industryMicrocirculationPercutaneous coronary interventionStroke VolumeEpithelial cell adhesion moleculeGeneral MedicineMiddle AgedEpithelial Cell Adhesion Moleculemedicine.diseaseMagnetic Resonance ImagingchemistryCardiologyST Elevation Myocardial InfarctionFemalebusinessCardiac magnetic resonancehuman activitiesRevista Española de Cardiología (English Edition)
researchProduct

Post-Reperfusion Lymphopenia and Microvascular Obstruction in ST-Segment Elevation Acute Myocardial Infarction

2009

The presence of microvascular obstruction after ST-segment elevation acute myocardial infarction is associated with a poor outcome. The pathophysiology of this process has not been fully defined. The aim of this study was to investigate the relationship between post-reperfusion lymphopenia and microvascular obstruction.This prospective study involved 212 patients with a first ST-segment elevation acute myocardial infarction who underwent reperfusion with thrombolytic agents or primary angioplasty and who had an open infarct-related artery. Serial measurements of lymphocyte, neutrophil and monocyte counts were taken. Cardiac magnetic resonance was used to detect microvascular obstruction dur…

Malemedicine.medical_specialtyMyocardial InfarctionInfarctionLymphopeniaInternal medicineHumansMedicineST segmentThrombolytic TherapyProspective StudiesVascular DiseasesMyocardial infarctionProspective cohort studybusiness.industryAngioplastyElectrocardiography in myocardial infarctionGeneral MedicineMiddle Agedmedicine.diseasemedicine.anatomical_structureMicrovesselsCardiologyFemalebusinessPerfusionTIMIArteryRevista Española de Cardiología (English Edition)
researchProduct

Evolution of 5 cardiovascular magnetic resonance–derived viability indexes after reperfused myocardial infarction

2007

The objective of this study was to evaluate the simultaneous evolution of 5 cardiovascular magnetic resonance-derived myocardial viability indexes.We studied 72 patients with a first ST-elevation myocardial infarction and sustained TIMI 3 flow. In the first week and in the sixth month of the study, using cardiovascular magnetic resonance imaging, we determined wall thickening (WT) and the following viability indexes: wall thickness, WT with low-dose dobutamine, microvascular perfusion in first-pass imaging, microvascular obstruction in late-enhancement imaging, and transmural extent of necrosis.In 250 dysfunctional segments, the evolution outcomes for the viability indexes were as follows: …

Malemedicine.medical_specialtyNecrosisReperfused myocardial infarctionMyocardial InfarctionMyocardial ReperfusionInternal medicinemedicineHumansMyocardial infarctionmedicine.diagnostic_testbusiness.industryMagnetic resonance imagingMiddle Agedmedicine.diseaseMagnetic Resonance ImagingCirculatory systemCardiologyFemaleDobutaminemedicine.symptomCardiology and Cardiovascular MedicineWall thicknessNuclear medicinebusinessTIMImedicine.drugAmerican Heart Journal
researchProduct

Hsp60 and heme oxygenase-1 (Hsp32) in acute myocardial infarction

2011

Heat shock proteins (Hsps) are produced in response to various stressors, including ischemia-reperfusion, and they can exit cells and reach the blood. In this pilot study, we determined serum levels of Hsp60 and heme-oxygenase-1 (HO-1; also named Hsp32) in subjects with acute myocardial infarction (AMI) to assess their clinical significance and potential prognostic value. We also performed a bioinformatics analysis of the 2 molecules in search of structural clues on the mechanism of their release from cells. We studied 40 patients consecutively admitted for AMI (male:female patient ratio = 20:20, mean age: 64 ± 13 years) and 40 matched controls. A blood sample was drawn for biochemical anal…

Malemedicine.medical_specialtyPathologyStatistics as TopicMyocardial InfarctionPilot ProjectsCreatineGastroenterologyCoronary artery diseasePathogenesischemistry.chemical_compoundPredictive Value of TestsPhysiology (medical)Internal medicinemedicineHumansClinical significancecardiovascular diseasesMyocardial infarctionacute myocardial infarction heme oxyenase-1 Hsp Hsp60AgedAged 80 and overbiologybusiness.industrySettore BIO/16 - Anatomia UmanaBiochemistry (medical)C-reactive proteinPublic Health Environmental and Occupational HealthCase-control studyComputational BiologyChaperonin 60General MedicineMiddle Agedmedicine.diseaseTroponinchemistryCase-Control Studiesbiology.proteinFemalebusinessHeme Oxygenase-1Follow-Up Studies
researchProduct

Impact of chronic total occlusion artery on 12-month mortality in patients with non-ST-segment elevation myocardial infarction treated by percutaneou…

2013

Abstract Background Three-vessel coronary artery disease is associated with high mortality in patients with non-ST-segment elevation myocardial infarction (NSTEMI). The purpose of this study was to assess the impact on 12‐month mortality of chronic total occlusion (CTO) in the non-infarct-related artery (non-IRA), as assessed by coronary angiography during percutaneous coronary intervention (PCI) for NSTEMI, of patients with 3-vessel disease. Methods The study included all of the NSTEMI patients with 3-vessel disease by coronary angiogram who were treated by PCI and who were registered in the prospective Polish Registry of Acute Coronary Syndromes (PL-ACS) from July 2007 to November 2009. T…

Malemedicine.medical_specialtyPercutaneous coronary interventions12-month mortalitymedicine.medical_treatmentMyocardial InfarctionCoronary artery diseasePercutaneous Coronary InterventionInternal medicinemedicineST segmentHumansMyocardial infarctionHospital MortalityProspective StudiesRegistriesAgedAged 80 and overNon‐ST-segment elevation myocardial infarctionbusiness.industryPercutaneous coronary interventionMiddle Agedmedicine.diseaseChronic total occlusionStenosismedicine.anatomical_structureTreatment OutcomeCoronary OcclusionConventional PCIInclusion and exclusion criteriaCardiologyFemaleCardiology and Cardiovascular MedicinebusinessArteryInternational journal of cardiology
researchProduct